UBS Oconnor LLC
- SEC CIK
- 0001132716
- Latest filing
- Aug 14, 2026
CERO holding history
Cero Therapeutics Holdings, Inc. in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CERO overviewAll 13F holders of CEROFull Q4 2025 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −190,898−100.0% | Sold out | Holders |
| Q3 2022 | 190,898 | $1.93M | <0.1% | −19,111−9.1% | Reduced | Holders |
| Q2 2022 | 210,009 | $2.11M | <0.1% | +210,009 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −206,308−100.0% | Sold out | Holders |
| Q4 2021 | 206,308 | $2.04M | <0.1% | +206,308 | New | Holders |